A detailed history of Deutsche Bank Ag\ transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Deutsche Bank Ag\ holds 4,924,992 shares of TEVA stock, worth $110 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,924,992
Previous 3,227,916 52.57%
Holding current value
$110 Million
Previous $52.5 Million 69.2%
% of portfolio
0.04%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$15.81 - $18.96 $26.8 Million - $32.2 Million
1,697,076 Added 52.57%
4,924,992 $88.7 Million
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $13.9 Million - $18.9 Million
1,085,584 Added 50.67%
3,227,916 $52.5 Million
Q1 2024

May 15, 2024

BUY
$10.67 - $14.43 $1.44 Million - $1.95 Million
134,969 Added 6.72%
2,142,332 $30.2 Million
Q4 2023

Feb 14, 2024

SELL
$8.12 - $10.63 $2.39 Million - $3.13 Million
-294,823 Reduced 12.81%
2,007,363 $21 Million
Q3 2023

Nov 09, 2023

SELL
$7.48 - $10.7 $4.81 Million - $6.89 Million
-643,658 Reduced 21.85%
2,302,186 $23.5 Million
Q2 2023

Aug 14, 2023

BUY
$7.2 - $9.47 $3.66 Million - $4.82 Million
508,615 Added 20.87%
2,945,844 $22.2 Million
Q1 2023

May 15, 2023

SELL
$8.36 - $11.37 $1.47 Million - $1.99 Million
-175,300 Reduced 6.71%
2,437,229 $21.6 Million
Q4 2022

Feb 13, 2023

BUY
$7.95 - $9.48 $664,683 - $792,603
83,608 Added 3.31%
2,612,529 $23.8 Million
Q3 2022

Nov 14, 2022

SELL
$6.86 - $11.95 $1.93 Million - $3.36 Million
-281,334 Reduced 10.01%
2,528,921 $20.4 Million
Q2 2022

Aug 11, 2022

SELL
$7.38 - $10.4 $703,601 - $991,525
-95,339 Reduced 3.28%
2,810,255 $21.1 Million
Q1 2022

May 13, 2022

SELL
$7.33 - $9.39 $1.04 Million - $1.33 Million
-142,108 Reduced 4.66%
2,905,594 $27.3 Million
Q4 2021

Feb 11, 2022

BUY
$7.9 - $10.19 $1.09 Million - $1.41 Million
138,056 Added 4.74%
3,047,702 $24.4 Million
Q3 2021

Nov 04, 2021

BUY
$8.38 - $10.18 $7.55 Million - $9.18 Million
901,421 Added 44.89%
2,909,646 $28.3 Million
Q2 2021

Aug 11, 2021

BUY
$9.9 - $11.56 $6.72 Million - $7.84 Million
678,527 Added 51.03%
2,008,225 $19.9 Million
Q1 2021

May 13, 2021

BUY
$10.34 - $12.81 $5.09 Million - $6.31 Million
492,679 Added 58.86%
1,329,698 $15.3 Million
Q4 2020

Feb 16, 2021

SELL
$8.61 - $11.04 $438,877 - $562,741
-50,973 Reduced 5.74%
837,019 $8.08 Million
Q3 2020

Nov 12, 2020

SELL
$8.57 - $12.69 $895,770 - $1.33 Million
-104,524 Reduced 10.53%
887,992 $8 Million
Q2 2020

Aug 13, 2020

SELL
$8.12 - $13.12 $697,597 - $1.13 Million
-85,911 Reduced 7.97%
992,516 $12.2 Million
Q1 2020

May 14, 2020

BUY
$6.69 - $13.45 $975,368 - $1.96 Million
145,795 Added 15.63%
1,078,427 $9.68 Million
Q4 2019

Feb 14, 2020

SELL
$6.53 - $10.72 $5.71 Million - $9.37 Million
-874,025 Reduced 48.38%
932,632 $9.14 Million
Q3 2019

Nov 14, 2019

SELL
$6.16 - $9.6 $18 Million - $28.1 Million
-2,927,356 Reduced 61.84%
1,806,657 $12.4 Million
Q2 2019

Aug 14, 2019

BUY
$8.12 - $15.72 $25.4 Million - $49.2 Million
3,127,190 Added 194.62%
4,734,013 $43.7 Million
Q1 2019

May 15, 2019

SELL
$15.58 - $20.01 $20.2 Million - $25.9 Million
-1,295,396 Reduced 44.63%
1,606,823 $25.2 Million
Q4 2018

Feb 14, 2019

BUY
$14.59 - $23.84 $15.1 Million - $24.7 Million
1,036,109 Added 55.52%
2,902,219 $44.7 Million
Q3 2018

Nov 14, 2018

SELL
$21.06 - $25.65 $52.8 Million - $64.3 Million
-2,505,169 Reduced 57.31%
1,866,110 $40.2 Million
Q2 2018

Aug 14, 2018

SELL
$16.77 - $24.71 $16.2 Million - $23.8 Million
-963,821 Reduced 18.07%
4,371,279 $106 Million
Q1 2018

Oct 18, 2019

BUY
$16.68 - $22.07 $6.19 Million - $8.19 Million
371,185 Added 7.48%
5,335,100 $91.2 Million
Q1 2018

May 15, 2018

BUY
$16.68 - $22.07 $46.1 Million - $61 Million
2,764,517 Added 125.69%
4,963,915 $84.8 Million
Q4 2017

Feb 14, 2018

BUY
$11.23 - $19.1 $1.75 Million - $2.98 Million
155,907 Added 7.63%
2,199,398 $41.7 Million
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $31.5 Million - $65.7 Million
2,043,491
2,043,491 $36 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.